| P2093 | author name string | Edward Litton | |
| | Jolene Lim | |
| P2860 | cites work | Oral iron supplements for children in malaria-endemic areas | Q24186101 |
| | Iron therapy for pre-operative anaemia | Q24186979 |
| | Pharmacological Targeting of the Hepcidin/Ferroportin Axis | Q26738350 |
| | Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials | Q26829377 |
| | Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation | Q28186993 |
| | Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women--PREFER a randomized, placebo-controlled study | Q28538067 |
| | Siderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal therapy | Q30243906 |
| | The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system | Q33953768 |
| | Long-term cognitive impairment after critical illness | Q34374900 |
| | Anemia of chronic disease. | Q34401570 |
| | Prevalence of iron deficiency on ICU discharge and its relation with fatigue: a multicenter prospective study. | Q34446768 |
| | Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction | Q34667528 |
| | Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. | Q34761547 |
| | Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations | Q35631492 |
| | A randomized trial of intravenous and oral iron in chronic kidney disease | Q36108862 |
| | Iron, oxidative stress and human health | Q36231332 |
| | Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind pl | Q36402607 |
| | Iron in infection and immunity | Q36913895 |
| | The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial | Q36992752 |
| | Iron supplementation to treat anaemia in adult critical care patients: a systematic review and meta-analysis | Q37295004 |
| | Review on iron and its importance for human health | Q37723220 |
| | Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial | Q38376481 |
| | Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants | Q38704288 |
| | Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials | Q38715116 |
| | The Right Ventricle in ARDS. | Q38749628 |
| | International consensus statement on the peri-operative management of anaemia and iron deficiency. | Q39084470 |
| | Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls | Q39432507 |
| | Iron Parameters Determine the Prognosis of Critically Ill Patients | Q39954397 |
| | Serum iron parameters in the early post-transplant period and infection risk in kidney transplant recipients | Q42248581 |
| | Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia | Q43137967 |
| | Ferric carboxymaltose in patients with heart failure and iron deficiency | Q43240282 |
| | Blunted erythropoietic response to anemia in multiply traumatized patients | Q43617635 |
| | Intravenous Iron Therapy in Patients Undergoing Cardiovascular Surgery: A Narrative Review | Q47220304 |
| | The ACTA PORT-score for predicting perioperative risk of blood transfusion for adult cardiac surgery. | Q47246680 |
| | Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women | Q47411042 |
| | Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial | Q47745978 |
| | Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia | Q48178769 |
| | Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure | Q48716818 |
| | Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : A randomized trial of IV iron in critical illness. | Q50226676 |
| | Iron-restricted erythropoiesis and risk of red blood cell transfusion in the intensive care unit: a prospective observational study. | Q50437950 |
| | Transfusion practice and guidelines in Australian and New Zealand intensive care units. | Q50578804 |
| | Guideline for the laboratory diagnosis of functional iron deficiency. | Q51076582 |
| | Pulmonary Arterial Hypertension: Iron Matters. | Q55237927 |
| | Iron and infection | Q56487621 |
| | Association of iron status with the risk of bloodstream infections: results from the prospective population-based HUNT Study in Norway | Q57172457 |
| | Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: a nested cohort study | Q58755798 |
| | Body iron status in critically ill patients: significance of serum ferritin | Q69639855 |
| | Unrecognised iron deficiency in critical illness | Q77719353 |
| | Prognostic impact of iron parameters in patients undergoing allo-SCT | Q83601881 |
| | Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure | Q84582099 |
| | Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: A Randomized, Double-Blind, Placebo-Controlled Study | Q90276372 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 81 | |
| P577 | publication date | 2019-03-09 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Iron Metabolism: An Emerging Therapeutic Target in Critical Illness | |
| P478 | volume | 23 | |